中山醫學大學機構典藏 CSMUIR:作者相關文件
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 17921/22936 (78%)
造訪人次 : 7496150      線上人數 : 552
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋

    類別瀏覽

    正在載入社群分類, 請稍候....

    年代瀏覽

    正在載入年代分類, 請稍候....

    "Tseng, JS"的相關文件 

    回到依作者瀏覽

    顯示 9 項.

    類別 日期 題名 作者 檔案
    [中山醫學大學研究成果] 期刊論文 2021 The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M Huang, YH; Tseng, JS; Hsu, KH; Chen, KC; Su, KY; Yu, SL; Chen, JJW; Yang, TY; Chang, GC
    [中山醫學大學研究成果] 期刊論文 2021 Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment Tseng, JS; Hsu, KH; Zheng, ZR; Yang, TY; Chen, KC; Huang, YH; Su, KY; Yu, SL; Chang, GC
    [中山醫學大學研究成果] 期刊論文 2021 Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma <= 2 cm in size: A retrospective cohort study Wu, JJ; Wu, CY; Wu, CY; Wang, CL; Yang, TY; Tseng, JS; Hsu, KH; Huang, YH; Hsu, CP; Chuang, CY; Lin, CH; Tseng, CH; Chen, KC; Chang, GC
    [中山醫學大學研究成果] 期刊論文 2021 Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC
    [中山醫學大學研究成果] 期刊論文 2021 Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients Hsu, KH; Huang, JW; Tseng, JS; Chen, KW; Weng, YC; Yu, SL; Yang, TY; Huang, YH; Chen, JJ; Chen, KC; Chang, GC
    [中山醫學大學研究成果] 期刊論文 2021 Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response Su, SF; Liu, CH; Cheng, CL; Ho, CC; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chen, HW; Chang, GC; Yu, SL; Li, KC
    [中山醫學大學研究成果] 期刊論文 2021 The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study Huang, YH; Hung, JY; Ko, HW; Su, PL; Lai, CL; Chang, HC; Hsia, TC; Lin, SH; Wu, KL; Yang, CT; Su, WC; Chu, YC; Wang, CC; Liao, WY; Lin, YT; Lin, CH; Lin, MC; Hsu, KH; Tseng, JS; Yang, TY; Chen, KC; Lee, MH; Yu, SL; Ho, CC; Chang, GC
    [中山醫學大學研究成果] 期刊論文 2020 ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients Chang, GC; Yang, TY; Chen, KC; Hsu, KH; Huang, YH; Su, KY; Yu, SL; Tseng, JS
    [中山醫學大學研究成果] 期刊論文 2020 Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma Raghav, L; Chang, YH; Hsu, YC; Li, YC; Chen, CY; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chuang, CY; Lee, MH; Wang, CL; Chen, HW; Yu, SL; Su, SF; Yuan, SS; Chen, JJW; Ho, SY; Li, KC; Yang, PC; Chang, GC; Chen, HY

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋